SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-016168
Filing Date
2020-06-11
Accepted
2020-06-11 16:18:15
Documents
1
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3922
  Complete submission text file 0000899243-20-016168.txt   5332
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Agger Mette Kirstine (Reporting) CIK: 0001722234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 20957385